Media Inquiries
Justin Jackson or
Michelle Szwarcberg
Burns McClellan
(212) 213-0006------------------------------------------------
Press Releases
XDx Announces Highmark's Coverage of AlloMap® for Monitoring Heart Transplant Rejection
November 8th, 2011
Blue Shield of California Considers AlloMap® Necessary for Heart Transplant Recipients.
August 17th, 2011
Anthem Blue Cross Has Determined AlloMap® Necessary for Heart Transplant Recipients.
June 8th, 2011
Studies Presented at 31st Annual ISHLT Meeting Expand Understanding of AlloMap®.
April 15th, 2011
XDx Announces that AlloMap® has been CE Marked in the European Union.
April 13th, 2011
XDx's AlloMap® Considered 'Medically Necessary' by Aetna Inc. for Heart Transplant Recipients
March 8th, 2011
XDx Approved as a Continuing Education Provider by the American Board for Transplant Certification.
March 8th, 2011
XDx and LabCorp Enter Into Expanded North American Agreement for XDx's AlloMap® Molecular Expression Tests.
February 7th, 2011
XDx Announces New $12.5 Million Multi-draw Term Loan Facility with GE Capital,Healthcare Financial Services.
January 28th, 2011
XDx CEO Pierre Cassigneul to Speak at New Frontiers in Personalized Medicine Conference in Washington, D.C.
January 3rd, 2011
XDx Announces Completion of Enrollment for Clinical Trial in the Early Months After Heart Transplant at Cedars-Sinai Heart Institute
December 16th, 2010
CTAF Unanimously Agrees that XDx’s AlloMap® Meets All Technology Assessment Criteria
November 8th, 2010
XDx Receives Qualifying Therapeutic Discovery Project Award Funding
November 5th, 2010
XDx Appoints New VP of Corporate Development and Legal Affairs
September 8th, 2010
XDx’s AlloMap® Recommended for Non-Invasive Monitoring of Acute Cellular Rejection in New ISHLT Guidelines
August 12th, 2010
International Society for Heart & Lung Transplantation and XDx Announce Results of IMAGE Study
April 22nd, 2010
XDx Announces Plenary Session Presentation of IMAGE Trial Results
April 16th, 2010
XDx Appoints New Chief Financial Officer
January 5th, 2010
XDx to Present at the J.P. Morgan 28th Annual Healthcare Conference
January 5th, 2010
XDx to Present at the Piper Jaffray 21st Annual Healthcare Conference
November 25th, 2009
XDx to Present at the JMP Securities Healthcare Focus Conference
September 30th, 2009
XDx to Present at the Thomas Weisel 2009 Healthcare Conference
September 3rd, 2009
XDx Completes Series G Financing
August 5th, 2009
XDx to Present at the Future Leaders in the Biotech Industry Conference
March 26, 2009
XDx Selected to Present at InsideVenture’s Debut Investor Conference
March 23, 2009
XDx and Bristol-Myers Squibb Enter into Pharmacogenomics Collaboration
January 9, 2009
XDx to Present at the 2008 In Vitro Diagnostic Regulatory and Reimbursement Conference
November, 2008
XDx to Present at the Third Annual JMP Securities Healthcare Focus Conference
October, 2008
FDA Clears Test to Help Doctors Manage Heart Transplant Patients
August, 2008
XDx’s AlloMap® Gene Expression Test Cleared by U.S. Food and Drug Administration
August, 2008
Personalized Medicine Coalition Announces Two New Board Members
July, 2008
XDx Appoints Industry Veteran Jay M. Moyes as Chief Financial Officer
May, 2008
XDx Files Reexamination Request for Source MDx Patent
February, 2008
XDx, Inc. Files Registration Statement for Proposed Initial Public Offering
October, 2007
XDx and University of Minnesota Establish Lupus Collaboration
February, 2007
XDx to Present at BIO CEO & Investor Conference
February, 2007
Independent Clinical Data Confirms Accuracy of Gene Expression Test for Heart Transplant Patients
January, 2007
XDx to Present at 2007 JP Morgan Healthcare Conference
January, 2007
XDx Announces Appointment of Dr. Mitchell Nelles to Vice President R&D, Technical Operations
January, 2007